Trials / Terminated
TerminatedNCT00931996
Oculomotor and Spatial Cognition Deficits in Schizophrenia
Clinical and Computational Studies of Dopamine Function in Schizophrenia
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- All
- Age
- 15 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
DESCRIPTION: (Verbatim from the Applicant's Abstract) Abnormalities of eye movement control and spatial cognition are well-established deficits in schizophrenia. However, the regional disturbances in brain function causing these deficits are not yet known. This application proposes a series of integrated behavioral studies designed to identify causes of deficits in schizophrenia.
Detailed description
We will be assessing clinical symptoms and cognition before and after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antipsychotic | Risperidone is the first line antipsychotic followed by others per clinician choice. Flexible dosing QD x 4-6 weeks. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2009-07-02
- Last updated
- 2013-01-24
- Results posted
- 2013-01-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00931996. Inclusion in this directory is not an endorsement.